Status:
UNKNOWN
Developement and Evaluation of Serological Assays for COVID-19
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of the study aims to evaluate serological assays of virus Covid-19.
Detailed Description
This is a retrospective monocentric study, which will include the patients who have hospitalized in Ambroise Paré Hospital and have sampling sent to the Laboratory of Microbiology of the hospital betw...
Eligibility Criteria
Inclusion
- Patient ≥ 18 years;
- Have molecular diagnosis of positive or negative result in Covid-19 virus by the Laboratory of Microbiology in Ambroise Paré Hospital;
- Have diagnosed of a viral infection in respiratory.
Exclusion
- \- Patient refusal.
Key Trial Info
Start Date :
July 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04377763
Start Date
July 15 2020
End Date
March 1 2021
Last Update
February 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory of microbiology of hospital hygiene, Ambroise Paré Hospital, APHP
Boulogne-Billancourt, France, 92100